KALA BIO, Inc.: retained earnings or deficit
Retained earnings or deficit for KALA BIO, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All KALA BIO, Inc. financial histories
What this measure means
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
Exact concept: us-gaap:RetainedEarningsAccumulatedDeficit. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | -694,900,000 | USD | 2026-04-15 | 10-K · 0001104659-26-043782 |
| At date | 2024-12-31 | -667,920,000 | USD | 2026-04-15 | 10-K · 0001104659-26-043782 |
| At date | 2023-12-31 | -629,409,000 | USD | 2025-03-31 | 10-K · 0001558370-25-004081 |
| At date | 2022-12-31 | -587,210,000 | USD | 2024-03-29 | 10-K · 0001558370-24-004326 |
| At date | 2021-12-31 | -542,388,000 | USD | 2023-03-03 | 10-K · 0001558370-23-002746 |
| At date | 2020-12-31 | -399,783,000 | USD | 2022-03-29 | 10-K · 0001558370-22-004624 |
| At date | 2019-12-31 | -295,456,000 | USD | 2021-02-25 | 10-K · 0001558370-21-001797 |
| At date | 2018-12-31 | -201,109,000 | USD | 2020-02-12 | 10-K · 0001558370-20-000733 |
| At date | 2017-12-31 | -134,371,000 | USD | 2019-03-12 | 10-K · 0001558370-19-001825 |
| At date | 2016-12-31 | -92,137,000 | USD | 2018-04-02 | 10-K · 0001558370-18-002697 |
Related financial histories
- KALA BIO, Inc.: total assets
- KALA BIO, Inc.: total liabilities
- KALA BIO, Inc.: stockholders equity
- KALA BIO, Inc.: cash and cash equivalents
- KALA BIO, Inc.: net income or loss
- KALA BIO, Inc.: operating cash flow
- KALA BIO, Inc.: capital expenditure payments
- KALA BIO, Inc.: revenue
- KALA BIO, Inc.: financing cash flow
- KALA BIO, Inc.: investing cash flow
- KALA BIO, Inc.: basic weighted-average shares
- KALA BIO, Inc.: diluted weighted-average shares
- KALA BIO, Inc.: basic earnings per share
- KALA BIO, Inc.: diluted earnings per share
- KALA BIO, Inc.: net property, plant and equipment
- KALA BIO, Inc.: share-based compensation expense
- KALA BIO, Inc.: operating income or loss
- KALA BIO, Inc.: current assets
- KALA BIO, Inc.: interest expense
- KALA BIO, Inc.: current liabilities
- KALA BIO, Inc.: current accounts payable
- KALA BIO, Inc.: net current accounts receivable
- KALA BIO, Inc.: operating expenses
- KALA BIO, Inc.: net inventory
- KALA BIO, Inc.: selling, general and administrative expense
- KALA BIO, Inc.: research and development expense
Inspect the source
- Entity
- KALA BIO, Inc. / CIK 0001479419
- Captured
- 2026-09-20T09:08:47.092Z
- SEC response SHA-256
29f0e958f07019914b4cd1bb8afa2c4b328082c5da8bf6fe4452eddabcaf41d1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001479419.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))